• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用卡尔加里抑郁量表评估精神分裂症患者的抑郁症状及其对结局的影响。

Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale.

机构信息

Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany.

出版信息

Acta Psychiatr Scand. 2011 Mar;123(3):228-38. doi: 10.1111/j.1600-0447.2010.01608.x. Epub 2010 Oct 4.

DOI:10.1111/j.1600-0447.2010.01608.x
PMID:21029053
Abstract

OBJECTIVE

To examine depressive symptoms, their course during treatment, and influence on outcome.

METHOD

Weekly Calgary Depression Scale for Schizophrenia ratings were performed in 249 inpatients with schizophrenia. Early response was defined as a 20% reduction in the total score of the Positive and Negative Syndrome Scale for Schizophrenia from admission to week 2, response as a 50% reduction in the total score of the Positive and Negative Syndrome Scale for Schizophrenia (PANSS) from admission to discharge and remission according to the consensus criteria.

RESULTS

Thirty six per cent of the patients were depressed at admission, with 23% of them still being depressed at discharge. Depressed patients scored significantly higher on the PANSS negative and general psychopathology subscore, featured more impairments in subjective well-being (P < 0.0001) and functioning (P < 0.0001). They suffered from more suicidality (P = 0.0021), and had greater insight into their illness (P = 0.0105). No significant differences were found regarding early response, response, and remission.

CONCLUSION

Patients with depressive symptoms should be monitored closely, given the burden of negative symptoms, their impairments in well-being and functioning and the threat of suicidality.

摘要

目的

研究抑郁症状、治疗期间的病程变化及其对治疗结果的影响。

方法

对 249 例精神分裂症住院患者每周进行一次 Calgary 抑郁量表评估。早期反应定义为从入院到第 2 周时阳性和阴性综合征量表(PANSS)总分降低 20%,反应定义为从入院到出院时 PANSS 总分降低 50%,根据共识标准判断缓解。

结果

入院时有 36%的患者抑郁,其中 23%的患者在出院时仍有抑郁。抑郁患者的 PANSS 阴性和一般精神病学子量表评分显著更高,主观幸福感(P < 0.0001)和功能(P < 0.0001)受损更多。他们自杀风险更高(P = 0.0021),对疾病的认识更深刻(P = 0.0105)。早期反应、反应和缓解之间没有显著差异。

结论

应密切监测有抑郁症状的患者,因为他们存在明显的阴性症状负担、幸福感和功能受损以及自杀风险。

相似文献

1
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale.应用卡尔加里抑郁量表评估精神分裂症患者的抑郁症状及其对结局的影响。
Acta Psychiatr Scand. 2011 Mar;123(3):228-38. doi: 10.1111/j.1600-0447.2010.01608.x. Epub 2010 Oct 4.
2
[Evaluation of depressive symptoms among schizophrenic patients during psychoeducation program].[精神分裂症患者在心理教育项目期间抑郁症状的评估]
Psychiatr Pol. 2002 Nov-Dec;36(6 Suppl):257-64.
3
Gender and affect in schizophrenia.
Can J Psychiatry. 1996 Jun;41(5):265-8.
4
The relationship of marital status and clinical characteristics in middle-aged and older patients with schizophrenia and depressive symptoms.中年及老年精神分裂症伴抑郁症状患者的婚姻状况与临床特征的关系
Ann Clin Psychiatry. 2010 Aug;22(3):172-9.
5
Suicidal ideation in patients with schizophrenia.精神分裂症患者的自杀意念
Isr J Psychiatry Relat Sci. 2009;46(3):195-203.
6
[Evaluation of depressive syndromes in the course of schizophrenia with the use of Calgary scale in patients from the inpatient hospital care].[运用卡尔加里量表对住院精神科护理的精神分裂症患者病程中的抑郁综合征进行评估]
Psychiatr Pol. 1998 Jan-Feb;32(1):37-45.
7
[Instruments of depression assessment in schizophrenia].[精神分裂症抑郁评估工具]
Actas Esp Psiquiatr. 2001 Jul-Aug;29(4):259-68.
8
The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.健康对照组中用于精神分裂症的卡尔加里抑郁评定量表:心理测量特性及参考值
J Affect Disord. 2005 Sep;88(1):69-74. doi: 10.1016/j.jad.2005.04.005.
9
Assessing depression in schizophrenia: the Calgary Depression Scale.评估精神分裂症中的抑郁:卡尔加里抑郁量表
Br J Psychiatry Suppl. 1993 Dec(22):39-44.
10
Depressive symptoms and schizophrenia a psychopharmacological approach.抑郁症状与精神分裂症:一种精神药理学方法
Encephale. 1995 Sep-Oct;21(5):555-8.

引用本文的文献

1
Unraveling the complex relationships between anxiety, depression, and quality of life in schizophrenia: a network analysis study.解析精神分裂症中焦虑、抑郁与生活质量之间的复杂关系:一项网络分析研究
Eur Arch Psychiatry Clin Neurosci. 2025 Apr 23. doi: 10.1007/s00406-025-02011-1.
2
Guideline for pharmacological treatment of schizophrenia 2022.《2022年精神分裂症药物治疗指南》
Neuropsychopharmacol Rep. 2025 Mar;45(1):e12497. doi: 10.1002/npr2.12497. Epub 2024 Nov 25.
3
Modeling the Determinants of Subjective Well-Being in Schizophrenia.
精神分裂症主观幸福感决定因素的建模
Schizophr Bull. 2025 Jul 7;51(4):1118-1133. doi: 10.1093/schbul/sbae156.
4
A case of postpsychotic depression improved by switching antipsychotic monotherapy.一例抗精神病药单药治疗后精神病性抑郁症改善的病例。
Neuropsychopharmacol Rep. 2023 Mar;43(1):146-149. doi: 10.1002/npr2.12308. Epub 2022 Dec 8.
5
Burden of schizophrenia among Japanese patients: a cross-sectional National Health and Wellness Survey.日本患者的精神分裂症负担:一项横断面全国健康和福利调查。
BMC Psychiatry. 2022 Jun 18;22(1):410. doi: 10.1186/s12888-022-04044-5.
6
Association between depression in chronic phase and future clinical outcome of patients with schizophrenia.慢性期抑郁症与精神分裂症患者未来临床结局的关系。
Psychopharmacology (Berl). 2022 Mar;239(3):965-975. doi: 10.1007/s00213-022-06099-4. Epub 2022 Feb 21.
7
Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".日本神经精神药理学学会:《精神分裂症药物治疗指南》
Neuropsychopharmacol Rep. 2021 Sep;41(3):266-324. doi: 10.1002/npr2.12193. Epub 2021 Aug 12.
8
Depression among Patients with Schizophrenia in Ethiopian Mental Health Hospital: Association with Sociodemographic and Clinical Variables: A Cross-Sectional Study.埃塞俄比亚精神卫生医院精神分裂症患者的抑郁状况:与社会人口学和临床变量的关联:一项横断面研究
Depress Res Treat. 2021 Feb 9;2021:6697339. doi: 10.1155/2021/6697339. eCollection 2021.
9
Depressive Symptoms during an Acute Schizophrenic Episode: Frequency and Clinical Correlates.急性精神分裂症发作期间的抑郁症状:发生率及临床关联
Depress Res Treat. 2015;2015:674641. doi: 10.1155/2015/674641. Epub 2015 Nov 18.
10
Psychometric properties of the self-report version of the Quick Inventory of Depressive Symptoms (QIDS-SR₁₆) questionnaire in patients with schizophrenia.精神分裂症患者中抑郁症状快速自评量表(QIDS-SR₁₆)问卷自我报告版本的心理测量学特性。
BMC Psychiatry. 2014 Sep 3;14:247. doi: 10.1186/s12888-014-0247-2.